Accordingly, the most effective treatments are based on stimulation of immune responses against CEACAM5.43 Our results suggest that the development of novel therapeutic agents directly targeting CEACAM5 could be effective in inhibiting tumor outgrowth in the metastatic setting. This evidence concerns the gene CEACAM5 and neoplasm.